Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Monitored issues related to Pediatric Review Vouchers; S. 2689 the REGROW Act and H.R. 34, The 21st Century Cures Act.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER